Gut · 1987 · 153 citations · 10 references
MedicinePharmacologyPharmacotherapyBowel ManagementGastroenterologyGastrointestinal PharmacotherapyBowel Function AssessmentConstipation ManagementFunctional Gastrointestinal DisordersGastrointestinal PharmacologyIrritable Bowel SyndromeConstipation TransitIbs-constipation PredominantIrritable Bowel Syndrome PharmacotherapyIrritable Bowel Syndrome Placebo ResponseIrritable Bowel Syndrome TreatmentPlacebo ComparatorsTransit Time Effects
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo group, while constipation significantly improved in patients taking ispaghula (p = 0.026). Transit time decreased significantly in those taking ispaghula compared with placebo (p = 0.001), especially in patients with initially high transit times. Abdominal pain and bloating improved in both groups, with no significant differences between ispaghula and placebo. Four of the eight withdrawals on ispaghula and 10 of the 15 withdrawals on placebo were because of treatment failure. Ispaghula significantly improves overall well being in patients with irritable bowel syndrome, and in those with constipation favourably affects bowel habit and transit time.
10
A new method for studying gut transit times using radioopaque markers
John Hinton, J E Lennard‐Jones, Aneurin Young · Gut · 1969 · 836 citations · Full text
Non-colonic features of irritable bowel syndrome.
Peter J. Whorwell, May F. McCallum, Francis Creed et al. · Gut · 1986 · 471 citations · Full text
Medicine, Psychiatry, Dysphagia +11
A DOUBLE-BLIND TRIAL OF THE EFFECT OF WHEAT BRAN ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME
J. Søltoft, Bent Krag, E Gudmand-Høyer et al. · The Lancet · 1976 · 144 citations